Skip to main content

Table 5 Kidney disease outcomes among the 454 Tanzanian adult study participants

From: Hypertension, kidney disease, HIV and antiretroviral therapy among Tanzanian adults: a cross-sectional study

Variable HIV-negative controls HIV-infected, ART-naive P-value versus control HIV-infected, on ART P-value versus control
Proportion (%)
Median [IQR] (number = 153) (number = 151) (number = 150)
Kidney disease a 39 (25.6%) 52 (34.4%) 0.09 62 (41.3%) 0.004
Creatinine (mmol/L) 68.3 [55.6 to 81.1] 70.9 [57.9 to 89] 0.49 64.3 [54.7 to 81.8] 0.69
eGFR 106.5 [78.8 to 119.3] 104.9 [79.9 to 116.7] 0.62 104.4 [82.1 to 115.6] 0.67
eGFR <60 mL/min 20 (13.1%) 19 (12.6%) 0.89 16 (10.7%) 0.52
Microalbuminuria 31 (20.3%) 43 (28.5%) 0.10 58 (38.7%) 0.001
  1. aThe primary kidney disease outcome: defined as microalbuminuria and/or eGFR <60 mL/min. ART, antiretroviral therapy; eGFR, estimated glomerular filtration rate; IQR, interquartile ratio.